Akero Therapeutics (AKRO) News Today $46.41 -0.14 (-0.30%) Closing price 04:00 PM EasternExtended Trading$46.22 -0.18 (-0.40%) As of 05:03 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock AKRO Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Akero Therapeutics, Inc. (NASDAQ:AKRO) Receives $81.14 Consensus Target Price from BrokeragesSeptember 30 at 2:47 AM | americanbankingnews.comAkero Therapeutics, Inc. (NASDAQ:AKRO) Receives Average Recommendation of "Buy" from BrokeragesSeptember 27, 2025 | marketbeat.com12,600 Shares in Akero Therapeutics, Inc. $AKRO Acquired by Strs OhioSeptember 22, 2025 | marketbeat.comVoya Investment Management LLC Has $3.34 Million Stock Position in Akero Therapeutics, Inc. $AKROSeptember 20, 2025 | marketbeat.comAkero Therapeutics (NASDAQ:AKRO) Shares Gap Up - Here's What HappenedSeptember 19, 2025 | marketbeat.comAkero Therapeutics, Inc. $AKRO Shares Acquired by Intech Investment Management LLCSeptember 17, 2025 | marketbeat.comAkero Therapeutics (NASDAQ:AKRO) Lowered to "Sell" Rating by Wall Street ZenSeptember 15, 2025 | marketbeat.comAkero Therapeutics (NASDAQ:AKRO) Insider Timothy Rolph Sells 553 SharesSeptember 13, 2025 | insidertrades.comAkero Therapeutics, Inc. $AKRO Shares Purchased by Woodline Partners LPSeptember 13, 2025 | marketbeat.comInsider Selling: Akero Therapeutics (NASDAQ:AKRO) Insider Sells 12,500 Shares of StockSeptember 12, 2025 | marketbeat.comAkero Therapeutics (NASDAQ:AKRO) Insider Timothy Rolph Sells 12,500 SharesSeptember 11, 2025 | insidertrades.comAkero Therapeutics, Inc. $AKRO Shares Acquired by Exome Asset Management LLCSeptember 11, 2025 | marketbeat.comFred Alger Management LLC Boosts Holdings in Akero Therapeutics, Inc. $AKROSeptember 10, 2025 | marketbeat.comAlliancebernstein L.P. Cuts Stock Position in Akero Therapeutics, Inc. $AKROSeptember 9, 2025 | marketbeat.comAdage Capital Partners GP L.L.C. Invests $7.89 Million in Akero Therapeutics, Inc. $AKROSeptember 9, 2025 | marketbeat.comBrokers Issue Forecasts for AKRO Q3 EarningsSeptember 9, 2025 | marketbeat.comAkero Therapeutics, Inc. (AKRO) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeptember 8, 2025 | seekingalpha.comNomura Holdings Inc. Invests $266,000 in Akero Therapeutics, Inc. $AKROSeptember 8, 2025 | marketbeat.comAmerican Century Companies Inc. Sells 102,396 Shares of Akero Therapeutics, Inc. $AKROSeptember 8, 2025 | marketbeat.comBrokers Offer Predictions for AKRO Q1 EarningsSeptember 7, 2025 | marketbeat.comEventide Asset Management LLC Makes New Investment in Akero Therapeutics, Inc. $AKROSeptember 7, 2025 | marketbeat.comPDT Partners LLC Cuts Stock Position in Akero Therapeutics, Inc. $AKROSeptember 7, 2025 | marketbeat.com440,000 Shares in Akero Therapeutics, Inc. $AKRO Acquired by EcoR1 Capital LLCSeptember 6, 2025 | marketbeat.comHC Wainwright Reiterates Buy Rating for Akero Therapeutics (NASDAQ:AKRO)September 6, 2025 | marketbeat.comAkero Therapeutics (NASDAQ:AKRO) COO Sells $576,000.00 in StockSeptember 5, 2025 | insidertrades.comAllostery Investments LP Invests $729,000 in Akero Therapeutics, Inc. $AKROSeptember 5, 2025 | marketbeat.comAkero Therapeutics, Inc. $AKRO Position Increased by Cubist Systematic Strategies LLCSeptember 5, 2025 | marketbeat.comAkero Therapeutics assumed with a Buy at H.C. WainwrightSeptember 4, 2025 | msn.comADAR1 Capital Management LLC Has $2.88 Million Position in Akero Therapeutics, Inc. $AKROSeptember 4, 2025 | marketbeat.comAkero Therapeutics, Inc. $AKRO Holdings Lowered by Alkeon Capital Management LLCSeptember 4, 2025 | marketbeat.comRedmile Group LLC Sells 295,932 Shares of Akero Therapeutics, Inc. $AKROSeptember 4, 2025 | marketbeat.comBaker BROS. Advisors LP Trims Holdings in Akero Therapeutics, Inc. $AKROSeptember 4, 2025 | marketbeat.com7,221 Shares in Akero Therapeutics, Inc. $AKRO Acquired by HighTower Advisors LLCSeptember 4, 2025 | marketbeat.comAkero Therapeutics, Inc. (NASDAQ:AKRO) Given Average Rating of "Buy" by AnalystsSeptember 3, 2025 | marketbeat.comPropel Bio Management LLC Sells 114,845 Shares of Akero Therapeutics, Inc. $AKROSeptember 2, 2025 | marketbeat.comNorthern Trust Corp Has $26.59 Million Stock Holdings in Akero Therapeutics, Inc. $AKROSeptember 2, 2025 | marketbeat.comAkero Therapeutics, Inc. $AKRO Shares Bought by Long Focus Capital Management LLCSeptember 1, 2025 | marketbeat.comTema Etfs LLC Lowers Stake in Akero Therapeutics, Inc. $AKROAugust 31, 2025 | marketbeat.comFORA Capital LLC Buys Shares of 16,473 Akero Therapeutics, Inc. $AKROAugust 30, 2025 | marketbeat.comAkero Therapeutics, Inc. $AKRO Shares Sold by Walleye Capital LLCAugust 30, 2025 | marketbeat.comInvesco Ltd. Purchases 18,658 Shares of Akero Therapeutics, Inc. $AKROAugust 30, 2025 | marketbeat.comAkero Therapeutics to Present at the Morgan Stanley 23rd Annual Global Healthcare ConferenceAugust 28, 2025 | globenewswire.comPrice T Rowe Associates Inc. MD Purchases 495,119 Shares of Akero Therapeutics, Inc. $AKROAugust 27, 2025 | marketbeat.comUniversity of Wisconsin Foundation Lowers Holdings in Akero Therapeutics, Inc. $AKROAugust 26, 2025 | marketbeat.com308,326 Shares in Akero Therapeutics, Inc. $AKRO Purchased by Nuveen LLCAugust 24, 2025 | marketbeat.comAlgert Global LLC Buys 15,195 Shares of Akero Therapeutics, Inc. $AKROAugust 23, 2025 | marketbeat.comRussell Investments Group Ltd. Buys 156,223 Shares of Akero Therapeutics, Inc. $AKROAugust 23, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Raises Stock Position in Akero Therapeutics, Inc. $AKROAugust 23, 2025 | marketbeat.comVanguard Group Inc. Has $171.26 Million Stock Position in Akero Therapeutics, Inc. $AKROAugust 23, 2025 | marketbeat.comWellington Management Group LLP Sells 1,440,721 Shares of Akero Therapeutics, Inc. $AKROAugust 22, 2025 | marketbeat.com Get Akero Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AKRO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AKRO Media Mentions By Week AKRO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AKRO News Sentiment▼0.670.53▲Average Medical News Sentiment AKRO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AKRO Articles This Week▼28▲AKRO Articles Average Week Get the Latest News and Ratings for AKRO and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Akero Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Dr. Reddy's Laboratories News Ascendis Pharma A/S News Viatris News Roivant Sciences News QIAGEN News Elanco Animal Health News BridgeBio Pharma News Moderna News Verona Pharma PLC American Depositary Share News Revolution Medicines News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AKRO) was last updated on 10/2/2025 by MarketBeat.com Staff From Our PartnersForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredThis Biotech has a clinical approach that intrigues investorsThis biotech is gearing up for Phase 2 trials with a strategy to unlock multiple approvals from one study. ...i2i Marketing Group, LLC | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredU.S. Government Sparking Crypto RallyU.S. Puts GDP on the Blockchain Could this spark the next crypto supercycle? Discover the altcoins poised t...Crypto 101 Media | SponsoredAmerica’s Lost StocksPorter Stansberry says the real fortunes aren’t in Tesla, Amazon, or AI — but in a handful of overlooked “lost...Porter & Company | SponsoredTrump Devises the Death of the IRS ☠️Trump has just signed an executive order creating America's first-ever National Investment Fund — a game-chang...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akero Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Akero Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AKRO Stock Alerts